Impact of a network system for providing proper inhalation technique by community pharmacists

Journal of Asthma

Volumn 49, Issue 5, 2012, Pages 535-541

  Takemura, Masaya ^a   Mitsui, Katsumi ^a   Ido, Masako ^a   Matsumoto, Masataka ^a   Koyama, Misuzu ^b   Inoue, Daiki ^a   Takamatsu, Kazufumi ^a   Itotani, Ryo ^a   Ishitoko, Manabu ^a   Suzuki, Shinko ^a   Aihara, Kensaku ^a   Sakuramoto, Minoru ^a   Kagioka, Hitoshi ^a   Fukui, Motonari ^a  

^a Kitano Hospital   (Japan)

^b Kita ku Pharmaceutical Association   (Japan)

Author keywords

adherence; asthma; asthma control; education; quality of life

Indexed keywords

ADULT; AGED; ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; HEALTH STATUS; HUMAN; INHALATION; INHALER; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; MEDICAL STAFF; PATIENT COMPLIANCE; PHARMACIST; PRESCRIPTION; QUESTIONNAIRE; SCORING SYSTEM;

ADMINISTRATION, INHALATION; ANTI-ASTHMATIC AGENTS; ASTHMA; COMMUNITY PHARMACY SERVICES; FEMALE; HUMANS; MALE; NEBULIZERS AND VAPORIZERS; PATIENT EDUCATION AS TOPIC; PHARMACISTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; STATISTICS, NONPARAMETRIC;

EID: 84862866153     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2012.663847     Document Type: Article

References (37)

1. Giraud V, Roche N. Misuse of corticosteroid metered-dose inhaler is associatedwith decreased asthma stability. EurRespir J 2002; 19:246-251. (Pubitemid 34162824)
2. Hesselink AE, Penninx BW, Wijnhoven HA, Kriegsman DM, van Eijk JT. Determinants of an incorrect inhalation technique in patients with asthma or COPD. Scand J Prim Health Care 2001; 19:255-260. (Pubitemid 34032753)
3. Ng TP, Lim TK, Abisheganaden J, Eng P, Sin FL. Factors associated with acute health care use in a national adult asthma management program. Ann Allergy Asthma Immunol 2006; 97:784-793. (Pubitemid 46032431)
4. Horsley MG, Bailie GR. Risk factors for inadequate use of pressurized aerosol inhalers. J Clin Pharm Ther 1988; 13:139-143.
5. Broeders ME, Molema J, Hop WC, Folgering HT. Inhalation profiles in asthmatics and COPD patients: reproducibility and effect of instruction. J Aerosol Med 2003; 16:131-141. (Pubitemid 36702667)
6. Giner J, Macian V, Hernandez C. Multicenter prospective study of respiratory patient education and instruction in the use of inhalers (EDEN study). Arch Bronconeumol 2002; 38:300-305.
7. Basheti IA, Reddel HK, Armour CL, Bosnic-Anticevich SZ. Improved asthma outcomes with a simple inhaler technique intervention by community pharmacists. J Allergy Clin Immunol 2007; 119:1537-1538. (Pubitemid 46860317)
8. Takemura M, Kobayashi M, Kimura K, Mitsui K, Masui H, Koyama M, Itotani R, Ishitoko M, Suzuki S, Aihara K, Matsumoto M, Oguma T, Ueda T, Kagioka H, Fukui M. Repeated instruction on inhalation technique improves adherence to the therapeutic regimen in asthma. J Asthma 2010; 47:202-208.
9. Armour C, Bosnic-Anticevich S, Brillant M, Burton D, Emmerton L, Krass I, Saini B, Smith L, Stewart K. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax 2007; 62:496-502. (Pubitemid 46910127)
10. Mehuys E, Van Bortel L, De Bolle L, Van Tongelen I, Annemans L, Remon JP, Brusselle G. Effectiveness of pharmacist intervention for asthma control improvement. Eur Respir J 2008; 31:790-799.
11. Global strategy for asthma management and prevention. Publication #02-3659. Updated 2004. Bethesda, MD: National Institute of Health/National Heart, Lung, and Blood Institute.
12. Wever AM, Wever-Hess J, Hensgens HE, Hermans J. Serum eosinophil cationic protein (ECP) in chronic asthma. Relationship to spirometry, flow-volume curves, PC20, and exacerbations. Respir Med 1994; 88:613-621. (Pubitemid 24296923)
13. Erickson SR, Coombs JH, Kirking DM, Azimi AR. Compliance from self-reported versus pharmacy claims data with metered-dose inhalers. Ann Pharmacother 2001; 35:997-1003. (Pubitemid 32880014)
14. De Smet BD, Erickson SR, Kirking DM. Self-reported adherence in patients with asthma. Ann Pharmacother 2006; 4:414-420.
15. Takemura M, Mitsui K, Itotani R, Ishitoko M, Suzuki S, Matsumoto M, Aihara K, Oguma T, Ueda T, Kagioka H, Fukui M. Relationships between repeated instruction on inhalation therapy, medication adherence, and health status in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2011; 6:97-104.
16. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24:67-74. (Pubitemid 16125389)
17. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens 2008; 10:348-354.
18. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991; 85(Suppl B):25-31, discussion 33-27.
19. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145:1321-1327.
20. Bouchet C, Guillemin F, Hoang Thi TH, Cornette A, Briancon S. Validation of the St George's Questionnaire for measuring the quality of life in patients with chronic obstructive pulmonary disease. Rev Mal Respir 1996; 13:43-46. (Pubitemid 26157813)
21. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:785-790.
22. Kesten S, Zive K, Chapman KR. Pharmacist knowledge and ability to use inhaled medication delivery systems. Chest 1993; 104: 1737-1742. (Pubitemid 23360103)
23. Mickle TR, Self TH, Farr M, Ikeda A, Koyama H, Izumi T. Evaluation of pharmacists' practice in patient education when dispensing a metereddose inhaler. Ann Pharmacother 1990; 24:927-930. (Pubitemid 20307241)
24. Nimmo CJ, Chen DN, Martinusen SM, Ustad TL, Ostrow DN. Assessment of patient acceptance and inhalation technique of a pressurized aerosol inhaler and two breath-actuated devices. Ann Pharmacother 1993; 27:922-927. (Pubitemid 23225686)
25. Corsico AG, Cazzoletti L, de Marco R, Janson C, Jarvis D, Zoia MC, Bugiani M, Accordini S, Villani S, Marinoni A, Gislason D, Gulsvik A, Pin I, Vermeire P, Cerveri I. Factors affecting adherence to asthma treatment in an international cohort of young and middle-aged adults. Respir Med 2007; 101:1363-1367. (Pubitemid 46667680)
26. Roberts RJ, Robinson JD, Doering PL, Dallman JJ, Steeves RA. A comparison of various types of patient instruction in the proper administration of metered inhalers. Drug Intell Clin Pharm 1982; 16:53-55.
27. Shim C, Williams Jr MH. The adequacy of inhalation of aerosol from canister nebulizers. Am J Med 1980; 69:891-894. (Pubitemid 11199861)
28. Kim C, Feldman HI, Joffe M, Tenhave T, Boston R, Apter AJ. Influences of earlier adherence and symptoms on current symptoms: a marginal structural models analysis. J Allergy Clin Immunol 2005; 115:810-814. (Pubitemid 40460858)
29. Ulrik CS, Backer V, Soes-Petersen U, Lange P, Harving H, Plaschke PP. The patient's perspective: adherence or non-adherence to asthma controller therapy? J Asthma 2006; 43:701-704. (Pubitemid 44722128)
30. De Boeck K, Alifier M, Warnier G. Is the correct use of a dry powder inhaler (Turbohaler) age dependent? J Allergy Clin Immunol 1999; 103:763-767. (Pubitemid 29297576)
31. Self TH, Brooks JB, Lieberman P, Ryan MR. The value of demonstration and role of the pharmacist in teaching the correct use of pressurized bronchodilators. Can Med Assoc J 1983; 128:129-131. (Pubitemid 13175245)
32. Cordina M, McElnay JC, Hughes CM. Assessment of a community pharmacy-based program for patients with asthma. Pharmacotherapy 2001; 21:1196-1203.
33. de Vries TW, van den Berg PB, Duiverman EJ, de Jong-van den Berg LTW. Effect of a minimal pharmacy intervention on improvement of adherence to asthma guidelines. Arch Dis Child 2009; 95:302-304.
34. McLean W, Gillis J, Waller R. The BC Community Pharmacy Asthma Study: a study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Can Respir J 2003; 10:195-202. (Pubitemid 36986739)
35. Barbanel D, Eldridge S, Griffiths C. Can a self-management programme delivered by a community pharmacist improve asthma control? A randomised trial. Thorax 2003; 58:851-854. (Pubitemid 37239231)
36. Petkova VB. Pharmaceutical care for asthma patients: a community pharmacy-based pilot project. Allergy Asthma Proc 2008; 29:55-61.
37. BuntingBA, CranorCW. TheAsheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc 2006;46:133-147. (Pubitemid 46037370)